# Hospital Infections, AMR and Antimicrobial Stewardship for NEET PG Microbiology: MRSA, ESBL, CRE, VRE, Drug Targets and India's Data

Source: https://tracknation.in/story/hospital-infections-amr-and-antimicrobial-stewardship-for-neet-pg-microbiology-mrsa-esbl-cre-vre-drug-targets-and-india-s-data (TrackNation — free UPSC notes with PYQs)

> NEET PG Microbiology: antibiotic targets, resistance mechanisms (MRSA, ESBL, carbapenemases, porin loss, VRE, efflux), how resistance spreads, India's resistance rates from ICMR, hospital-acquired pneumonia, CAUTI, surgical-site prophylaxis, hand hygiene, and stewardship with WHO AWaRe, with a diagram, hooks, MCQs and cards.

## Start Here

🎯 **Exam priority: High.** *Expect: drug class to target matching, the mechanism behind MRSA, ESBL, CRE and VRE, efflux and porins,
plasmid spread, India's resistance figures, HAP timing and organisms, CAUTI definition, timing of surgical prophylaxis, hand hygiene, the stewardship
definition and steps, and the AWaRe groups.*

CBME mapping: **MI10.1–10.5, MI11.1–11.3**. Fact-checked against OpenStax Microbiology, the ICMR Treatment Guidelines for Antimicrobial Use
(2019), the WHO AWaRe antibiotic book (2022) and the MSD Manual.

*Resistance, hospital infections and stewardship. Drawn by TrackNation.*

## Where Antibiotics Act (OpenStax 14.3)

*Where each antibiotic class acts on the bacterial cell, and the five ways bacteria resist. Drawn by TrackNation.*

- **Cell wall**: β-lactams (penicillins, cephalosporins, monobactams, carbapenems) bind **penicillin-binding proteins**;
**glycopeptides** bind peptidoglycan subunits; bacitracin blocks subunit transport. A fifth-generation cephalosporin acts on MRSA.

- **Protein synthesis**: **30S** — aminoglycosides, tetracyclines; **50S** — macrolides, lincosamides,
chloramphenicol, oxazolidinones.

- **Membranes**: polymyxin B, colistin, daptomycin. **Nucleic acids**: rifamycins (RNA polymerase), fluoroquinolones (DNA).
**Folate**: sulfonamides (PABA analogues) and trimethoprim.

## How Bacteria Resist (OpenStax 14.5, ICMR)

- Three strategies: **destroy or modify the drug**, **alter the target**, or **stop it entering or accumulating**.

- **ESBLs** inactivate all penicillins, cephalosporins and monobactams; **carbapenemases** are β-lactamases that break carbapenems;
*P. aeruginosa* also resists carbapenems by losing its **OprD porin**. **Efflux pumps** push out β-lactams, tetracyclines and
fluoroquinolones.

- **MRSA** gains a **new low-affinity PBP** (gene **mecA**) → resistance to virtually all β-lactams.
**VRE**: altered peptidoglycan target; spreads between patients on **health workers' hands**.

- Resistance genes ride on **plasmids and transposons** (horizontal transfer) or arise by mutation and are selected by **overuse, misuse,
underdosing and poor adherence**. Multidrug-resistant organisms are "superbugs"; CRE are a growing hospital threat.

- **India (ICMR 2019)**: **12–59%** of E. coli produce ESBL and up to **30%** carbapenemase; **Klebsiella** up to
**50%** carbapenem-resistant with rising polymyxin resistance; **MRSA** in up to **30%** of S. aureus.

## Healthcare-Associated Infections (MSD)

- **Hospital-acquired pneumonia**: develops **≥48 hours after admission**; commonest organisms **S. aureus, Pseudomonas** and
other gram-negative bacilli; the commonest HAI in the US.

- **CAUTI**: catheter in place **>2 consecutive days**; a **biofilm** protects bacteria; culture after replacing the
catheter.

- **Surgical-site prophylaxis**: antibiotic within **1 hour before incision** (2 hours for vancomycin and fluoroquinolones); redose
cephalosporins if surgery lasts >4 hours.

- Prevention: **hand hygiene** — health workers' hands are the commonest route of staphylococcal spread; alcohol hand rubs fail on visibly dirty
hands; device care; BMW segregation (article 03). A single skin-flora blood culture is usually contamination.

## Antimicrobial Stewardship (ICMR, WHO)

- **Definition (ICMR)**: coordinated interventions to measure and improve antibiotic use by choosing the **optimal drug, dose, duration
and route**.

- Steps: make a clinical diagnosis; **send cultures before starting empirical antibiotics**; start empirical therapy only where early treatment
helps; **"start smart, then focus"** — de-escalate to a single, narrower agent and stop when a non-infectious cause is found.

- **WHO AWaRe**: **Access** (narrow spectrum, safe), **Watch** (broader, for sicker patients or likely resistance) and
**Reserve**; WHO wants **≥60%** of national consumption from the Access group.

## Traps the Examiner Sets

- MRSA's resistance comes from a new low-affinity PBP (mecA), covering virtually all β-lactams.

- HAP is defined as pneumonia developing ≥48 hours after admission.

- Prophylaxis given after incision is too late.

- Alcohol hand rubs do not work well on visibly dirty hands.

- WHO wants at least 60% of antibiotic use to come from the Access group.

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **'Buy AT 30, CELLs at 50': aminoglycosides, tetracyclines on 30S; chloramphenicol, erythromycin (macrolides), linezolid, lincosamides on 50S** — drug targets

- 🧠 **Resistance 'DTE': Destroy the drug, Twist the target, Exclude entry** — mechanisms

- 🧠 **'MRSA Makes a new PBP; ESBL Eats Penicillins and cephalosporins'** — resistance

- 🧠 **'Two days in — it's hospital pneumonia'** — HAP

- 🧠 **'Start Smart, then Focus' — culture first, then de-escalate** — stewardship

## Rapid-Revision Cards

- β-lactams (PBPs), glycopeptides, bacitracin.

- Aminoglycosides, tetracyclines / macrolides, clinda, chloramph., linezolid.

- Rifampicin (RNA pol), FQs (DNA).

- Sulfonamides (PABA analogue), trimethoprim.

- Destroy drug, change target, block entry.

- New PBP (mecA).

- All penicillins, cephalosporins, monobactams.

- Carbapenemase; OprD loss (Pseudomonas).

- Altered target; spread by hands.

- β-lactams, tetracyclines, FQs.

- Plasmids, transposons.

- Overuse, misuse, underdosing, non-adherence.

- E. coli ESBL 12–59%, CP up to 30%.

- Carbapenem R up to 50%.

- Up to 30%.

- ≥48 h; S. aureus, Pseudomonas.

- Catheter >2 days; biofilm.

- Within 1 h of incision; redose >4 h.

- Fails on visibly dirty hands.

- Right drug, dose, duration, route.

- Access ≥60% of use.

## Sources

*Facts in this article were checked against these documents.*

- Microbiology (sections 13.3, 14.3, 14.5) — Parker N, Schneegurt M, Thi Tu A-H, Lister P, Forster BM (OpenStax), 2016 (link)

- Treatment Guidelines for Antimicrobial Use in Common Syndromes (2nd ed.) — Indian Council of Medical Research, 2019

- The WHO AWaRe (Access, Watch, Reserve) antibiotic book — World Health Organization, 2022

- MSD Manual Professional: Hospital-Acquired Pneumonia; CAUTI; Prevention of Surgical Site Infection; Staphylococcal Infections; Susceptibility Testing; Culture — Merck & Co. (MSD Manuals), 2024–26 (link)

- Competency Based Undergraduate Curriculum, Vol I: Microbiology (MI10.1–10.5, MI11.1–11.3) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, many of them ward scenarios.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** β-lactam antibiotics act by binding

- (a) the 30S ribosome

- (b) the 50S ribosome

- (c) penicillin-binding proteins

- (d) DNA gyrase

**Answer: (c)** — Cell wall synthesis.

**Q2.** Aminoglycosides and tetracyclines act on the

- (a) RNA polymerase

- (b) cell membrane

- (c) 50S ribosomal subunit

- (d) 30S ribosomal subunit

**Answer: (d)** — OpenStax.

**Q3.** Macrolides, lincosamides, chloramphenicol and oxazolidinones act on the

- (a) cell wall

- (b) 30S subunit

- (c) folate pathway

- (d) 50S ribosomal subunit

**Answer: (d)** — OpenStax.

**Q4.** Rifampicin acts by inhibiting

- (a) cell wall synthesis

- (b) folate synthesis

- (c) bacterial RNA polymerase

- (d) DNA gyrase

**Answer: (c)** — OpenStax.

**Q5.** Sulfonamides are structural analogues of

- (a) NAG

- (b) D-alanine

- (c) folic acid itself

- (d) para-aminobenzoic acid (PABA)

**Answer: (d)** — Folate pathway.

**Q6.** Polymyxins (colistin) act on the

- (a) cell wall transpeptidase

- (b) ribosome

- (c) DNA

- (d) bacterial membranes

**Answer: (d)** — OpenStax.

**Q7.** The three broad mechanisms of antimicrobial resistance are

- (a) mutation, transduction, conjugation

- (b) drug modification, target modification and reduced entry/accumulation

- (c) toxins, adhesins, enzymes

- (d) capsule, spores, flagella

**Answer: (b)** — OpenStax.

**Q8.** MRSA resists methicillin by acquiring

- (a) a β-lactamase

- (b) a new low-affinity penicillin-binding protein (mecA)

- (c) a thicker capsule

- (d) an efflux pump only

**Answer: (b)** — Resists virtually all β-lactams.

**Q9.** ESBL-producing gram-negative bacteria are resistant to

- (a) vancomycin

- (b) carbapenems only

- (c) all penicillins, cephalosporins and monobactams

- (d) aminoglycosides only

**Answer: (c)** — OpenStax.

**Q10.** Pseudomonas aeruginosa commonly resists carbapenems by

- (a) a new PBP

- (b) making ESBL only

- (c) reducing its OprD porin

- (d) thickening peptidoglycan

**Answer: (c)** — Reduced entry.

**Q11.** Vancomycin resistance in enterococci is due to

- (a) β-lactamase

- (b) efflux

- (c) modification of the peptidoglycan target

- (d) porin loss

**Answer: (c)** — VRE.

**Q12.** Efflux pumps commonly cause resistance to

- (a) polymyxins only

- (b) antifungals only

- (c) vancomycin only

- (d) β-lactams, tetracyclines and fluoroquinolones

**Answer: (d)** — OpenStax.

**Q13.** Resistance genes spread rapidly between bacteria mainly on

- (a) capsules

- (b) flagella

- (c) spores

- (d) plasmids and transposons

**Answer: (d)** — Horizontal gene transfer.

**Q14.** Drivers of antimicrobial resistance include

- (a) vaccination

- (b) culture-guided therapy

- (c) overuse, misuse, subtherapeutic dosing and poor adherence

- (d) hand hygiene

**Answer: (c)** — OpenStax.

**Q15.** According to ICMR (2019), ESBL production in Indian E. coli is up to

- (a) 90–100%

- (b) 5–10%

- (c) 1–2%

- (d) 12–59%

**Answer: (d)** — Carbapenemase up to 30%.

**Q16.** ICMR reports carbapenem resistance in Klebsiella pneumoniae in India of up to

- (a) 50%

- (b) 15%

- (c) 95%

- (d) 5%

**Answer: (a)** — Polymyxin resistance rising.

**Q17.** MRSA in India (ICMR 2019) is seen in up to

- (a) 30% of S. aureus isolates

- (b) 2%

- (c) 100%

- (d) 80%

**Answer: (a)** — ICMR.

**Q18.** Hospital-acquired pneumonia is defined as pneumonia developing

- (a) after discharge only

- (b) only on a ventilator

- (c) within 24 hours of admission

- (d) at least 48 hours after admission

**Answer: (d)** — MSD.

**Q19.** The commonest organisms in hospital-acquired pneumonia are

- (a) S. aureus, Pseudomonas and other gram-negative bacilli

- (b) Mycoplasma

- (c) viruses

- (d) pneumococcus and Haemophilus

**Answer: (a)** — MSD.

**Q20.** A UTI is called catheter-associated when the catheter has been in place for

- (a) any duration

- (b) more than 2 consecutive days

- (c) more than 2 hours

- (d) more than 2 weeks

**Answer: (b)** — MSD.

**Q21.** Surgical antibiotic prophylaxis should be given

- (a) the day before surgery

- (b) within 1 hour before incision

- (c) only if infection appears

- (d) after closure

**Answer: (b)** — 2 h for vancomycin, FQ.

**Q22.** Cephalosporin prophylaxis should be redosed if surgery lasts more than

- (a) 4 hours

- (b) 12 hours

- (c) 24 hours

- (d) 30 minutes

**Answer: (a)** — MSD.

**Q23.** The commonest route of spread of staphylococci in hospitals is

- (a) food

- (b) health workers' hands

- (c) water

- (d) air conditioning

**Answer: (b)** — Hand hygiene.

**Q24.** Alcohol hand rubs work by

- (a) denaturing proteins and disrupting membranes, but fail on visibly dirty hands

- (b) forming a barrier film

- (c) killing spores

- (d) oxidising DNA

**Answer: (a)** — OpenStax.

**Q25.** ICMR defines antimicrobial stewardship as interventions that optimise the antibiotic's

- (a) packaging

- (b) brand

- (c) price

- (d) choice, dose, duration and route

**Answer: (d)** — ICMR 2019.

**Q26.** Before starting empirical antibiotics in a septic patient, ICMR advises

- (a) starting colistin

- (b) avoiding cultures

- (c) sending cultures (e.g. two blood culture sets)

- (d) waiting 48 hours

**Answer: (c)** — ICMR.

**Q27.** 'Start smart, then focus' means

- (a) start appropriate empirical therapy, then de-escalate based on cultures

- (b) avoid antibiotics

- (c) use two drugs always

- (d) start with the broadest drugs forever

**Answer: (a)** — ICMR.

**Q28.** In WHO AWaRe, narrow-spectrum antibiotics with good safety are the

- (a) Restricted group

- (b) Access group

- (c) Watch group

- (d) Reserve group

**Answer: (b)** — WHO 2022.

**Q29.** WHO's target is that Access antibiotics make up at least

- (a) 60% of national consumption

- (b) 10%

- (c) 100%

- (d) 30%

**Answer: (a)** — WHO.

**Q30.** Carbapenemases are

- (a) β-lactamases that break down carbapenems

- (b) efflux pumps

- (c) PBPs

- (d) porins

**Answer: (a)** — WHO glossary.

### Active Recall

From memory: match antibiotic classes to targets, explain how MRSA, ESBL, carbapenem-resistant organisms and VRE resist, how resistance spreads, India's resistance figures, the definitions and prevention of HAP, CAUTI and surgical-site infection, and the principles of stewardship and AWaRe.
